Pathogenesis and therapeutic strategy in platinum resistance lung cancer

Platinum compounds (cisplatin and carboplatin) represent the most active anticancer agents in clinical use both of lung cancer in mono-and combination therapies. However, platinum resistance limits its clinical application. It is necessary to understand the molecular mechanism of platinum resistance...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biochimica et biophysica acta. Reviews on cancer 2021-08, Vol.1876 (1), p.188577-188577, Article 188577
Hauptverfasser:	Lv, Panpan, Man, Shuli, Xie, Lu, Ma, Long, Gao, Wenyuan
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemoresistance Lung cancer Platinum Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!